首页> 外文OA文献 >Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
【2h】

Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.

机译:干粉吸入器:几种有希望的替代载体冷冻干燥的甘露醇的几种大小级分的理化和雾化特性。

摘要

The purpose of this work was to evaluate the physicochemical and inhalation characteristics of different size fractions of a promising carrier, i.e., freeze-dried mannitol (FDM). FDM was prepared and sieved into four size fractions. FDMs were then characterized in terms of micromeritic, solid-state and bulk properties. Dry powder inhaler (DPI) formulations were prepared using salbutamol sulphate (SS) and then evaluated in terms of drug content homogeneity and in vitro aerosolization performance. The results showed that the crystalline state of mannitol was maintained following freeze-drying for all size fractions of FDM. All FDM particles showed elongated morphology and contained mixtures of α-, β- and δ-mannitol. In comparison to small FDM particles, FDMs with larger particle sizes demonstrated narrower size distributions, higher bulk and tap densities, lower porosities and better flowability. Regardless of particle size, all FDMs generated a significantly higher (2.2-2.9-fold increase) fine particle fraction (FPF, 37.5 ± 0.9%-48.6 ± 2.8%) of SS in comparison to commercial mannitol. The FPFs of SS were related to the shape descriptors of FDM particles; however, FPFs did not prove quantitative apparent relationships with either particle size or powder bulk descriptors. Large FDM particles were more favourable than smaller particles because they produced DPI formulations with better flowability, better drug content homogeneity, lower amounts of the drug depositing on the throat and contained lower fine-particle-mannitol. Optimized stable DPI formulations with superior physicochemical and pharmaceutical properties can be achieved using larger particles of freeze-dried mannitol (FDM).
机译:这项工作的目的是评估一种有前途的载体(即冻干甘露醇(FDM))的不同大小部分的理化和吸入特性。制备FDM并将其筛分为四个尺寸部分。然后根据微团,固态和本体性质表征FDM。使用硫酸沙丁胺醇(SS)制备干粉吸入器(DPI)制剂,然后根据药物含量均匀性和体外雾化性能进行评估。结果表明,冷冻干燥后,对于所有大小的FDM,甘露醇均保持结晶状态。所有FDM颗粒均表现出拉长的形态,并包含α-,β-和δ-甘露醇的混合物。与较小的FDM颗粒相比,具有较大粒径的FDM表现出较窄的尺寸分布,较高的堆积密度和振实密度,较低的孔隙率以及更好的流动性。不论粒径大小,与市售甘露醇相比,所有FDM均会产生明显更高的SS细颗粒级分(FPF,37.5±0.9%-48.6±2.8%)(FPF,37.5±0.9%-48.6±2.8%)。 SS的FPF与FDM颗粒的形状描述符有关。然而,FPFs并没有证明与颗粒大小或粉末体积描述符具有定量的表观关系。大FDM颗粒比小颗粒更有利,因为它们生产的DPI制剂具有更好的流动性,更好的药物含量均一性,更少的药物在喉咙上的沉积量以及更低的细颗粒甘露醇含量。使用较大颗粒的冻干甘露醇(FDM),可以获得具有优异的理化和药物特性的优化的稳定DPI制剂。

著录项

  • 作者

    Kaialy Waseem; Nokhodchi Ali;

  • 作者单位
  • 年度 2015
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号